ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 152 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2015. The put-call ratio across all filers is 1.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $11,876,000 | -27.4% | 168,915 | -26.8% | 1.49% | -27.5% |
| Q3 2016 | $16,361,000 | -1.0% | 230,628 | -31.7% | 2.06% | -12.3% |
| Q2 2016 | $16,521,000 | -13.3% | 337,788 | +12.2% | 2.34% | -6.8% |
| Q1 2016 | $19,062,000 | -17.7% | 301,091 | +45.8% | 2.52% | -7.6% |
| Q4 2015 | $23,172,000 | +16.3% | 206,559 | -0.2% | 2.72% | +17.9% |
| Q3 2015 | $19,925,000 | -25.0% | 206,880 | -20.3% | 2.31% | -14.4% |
| Q2 2015 | $26,584,000 | – | 259,633 | – | 2.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 38,100 | $2,928,000 | 1.67% |
| Opaleye Management Inc. | 80,000 | $6,149,000 | 1.59% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 410,000 | $31,517,000 | 1.06% |
| Opus Point Partners Management, LLC | 6,311 | $485,000 | 1.05% |
| SECTOR GAMMA AS | 68,015 | $5,228,000 | 0.87% |
| Capital Impact Advisors, LLC | 27,074 | $2,061,000 | 0.76% |
| FORTALEZA ASSET MANAGEMENT INC/ | 1,130 | $87,000 | 0.71% |
| CAPITAL INTERNATIONAL LTD /CA/ | 46,957 | $3,610,000 | 0.63% |
| Virtus ETF Advisers LLC | 8,794 | $676,000 | 0.60% |
| Rock Springs Capital Management LP | 200,000 | $15,374,000 | 0.59% |